Recent scientific advancements have shown that a lesser-known compound from the cannabis plant, cannabinol (CBN), may hold promise for treating neurological disorders such as Alzheimer’s and Parkinson’s disease. Researchers at the Salk Institute discovered that not only does CBN protect brain cells from age-related damage, but its chemically modified versions could be even more effective. With the prevalence of neurological disorders rising among the aging population, there is a pressing need for effective treatments. These diseases are characterized by the progressive degeneration of brain cells, leading to severe cognitive and motor function impairments.
Cannabinol (CBN), a compound derived from the cannabis plant, has emerged as a candidate for such treatments due to its neuroprotective properties, which are evident without the psychoactive effects associated with other cannabinoids like THC. CBN increases the ability to penetrate the brain, act faster, and provide stronger effects in protecting against cell death when compared to other drugs.
Also, when testing on patients with traumatic brain injuries, survival rates increased as well as recovery rate nearly doubled.
